Efficacy of Combination Antibiotic Therapy for Refractory Pediatric Inflammatory Bowel Disease.
Explore this paper's citation graph
Summary
Oral combination antibiotics appears to be an effective rescue and steroid-sparing therapy to induce remission in the short term in patients failing a biologic.
- Type
- article
- Published
- 2018-05-01
- Cited by
- 36
- References
- 25
- Access
- Open access
- OpenAlex
- https://openalex.org/W2801908163
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:73450708
Keywords
Medicine, Inflammatory bowel disease, Refractory (planetary science), Antibiotics, Inflammatory Bowel Diseases
References
- Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis
- Role of the microbiota in inflammatory bowel diseases.
- Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease
- Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up
- Long-Term Alteration of Intestinal Microbiota in Patients with Ulcerative Colitis by Antibiotic Combination Therapy
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- Vedolizumab as induction and maintenance therapy for Crohn's disease.
- Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
- Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
- Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
- Vedolizumab as induction and maintenance therapy for ulcerative colitis.
- Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines
- Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.
- Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
- Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease
- Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
- American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
- Environment dominates over host genetics in shaping human gut microbiota
Cited by
- Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects
- Clinical characteristics of colitis induced by taxane-based chemotherapy
- Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.
- Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al.
- Physiologically based pharmacokinetic‐pharmacodynamic evaluation of meropenem plus fosfomycin in paediatrics
- Maladies inflammatoires chroniques de l’intestin de l’adulte et microbiote
- Antibiotics for the induction and maintenance of remission in ulcerative colitis.
- Antibiotics in pediatric inflammatory bowel diseases: a systematic review
- The Potential Immunomodulatory Properties of Levornidazole Contribute to Improvement in Experimental Ulcerative Colitis
- Prägung in der Kindheit und Bedeutung im weiteren Leben
- Intermittent antibiotic treatment accelerated the development of colitis in IL-10 knockout mice.
- Doxycycline Phototoxicity: A Cautionary Tale for Travelers.
- Emerging Pharmacotherapy for Inflammatory Bowel Diseases.
- Stemming the Tide of Gastrointestinal Chronic Granulomatous Disease
- Pediatric Management of Crohn's Disease.
- Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease.
- Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis
- Degradation Of Tetracycline Antibiotic in Water by an Electro/Peroxydisulfate System Catalyzed with Fe2+ Loaded on Activated Carbon
- A Single-Center Study of Long-Term Effectiveness of Vedolizumab in Anti-TNF Refractory Pediatric Inflammatory Bowel Disease
- The epidemiology of inflammatory bowel disease: Clues to pathogenesis?
Related papers
- Origins and Directions of Inflammatory Bowel Disease, Early Studies of the “Nonspecific” Inflammatory Bowel Diseases
- A 5-year study on hospital discharges for pediatric inflammatory bowel diseases in Lombardia
- Mo1835 PREVALENCE OF OCULAR DISEASES IN INFLAMMATORY BOWEL DISEASE (IBD): A NATIONAL, POPULATION-BASED STUDY
- Monitoring Antibiotics and Inflammatory Markers in Human Blood: Impact in Choice of Antibiotic Therapy and used Methods
- Monitoring Antibiotics and Inflammatory Markers in Human Blood: Impact in Choice of Antibiotic Therapy and Used Methods
- Effect of antibiotic therapy on the sensitivity of indium-111-labeled leukocyte scans.
- Treatment and Prospects of Antibiotic-associated Colitis
- [Inflammatory bowel disease; symptoms and diagnosis of inflammatory bowel diseases].